TrialBMC cancer2013

Low Annexin A1 expression predicts benefit from induction chemotherapy in oral cancer patients with moderate or poor pathologic differentiation grade.

Dong-wang Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.